Abstract:Aim: To examine the effects of triptolide (TPL) on T-cell leukemia cells and identify their underlying mechanisms. Methods: The cytotoxicity of TPL was assessed by MTT assay. Cell apoptosis was determined using annexin V and DAPI staining and analyzed by flow cytometry or fluorescence microscopy. The activation of caspase pathways and the expression of nuclear factor κB (NF-κB) p65 were examined by Western blotting. Differences in microRNA (miRNA) expression in Molt-4 and Jurkat cells before and after TPL treatment were identified using microarrays and real-time RT-PCR, respectively. Results: TPL 20–160 nmol/L treatment potently inhibited cell growth and induced apoptosis in T-cell lymphocytic leukemia cell lines. Molt-4 and Jurkat cells, however, were more sensitive to TPL than L428 and Raji cells. After 24 h of treatment, bortezomib abrogated the growth of Molt-4 and Jurkat cells with an IC 50 of 15.25 and 24.68 nmol/L, respectively. Using Molt-4 cells, we demonstrated that treatment 20–80 nmol/L inhibited the translocation of NF-κB p65 from the cytoplasm to the nucleus and that phosphorylated NF-κB p65 in nuclear extracts was down-regulated in a dose-dependent manner. Similar results were also seen in Jurkat cells but not in L428 cells, as these cells are resistant to TPL and bortezomib (a NF-κB inhibitor). Twenty-three miRNAs were differentially expressed after TPL treatment. Functional analysis revealed that TPL treatment could inhibit expression of miR-16-1 * and that transfection of miR-16-1 * led to significantly decreased apoptosis induced by TPL. Conclusion: Our in vitro studies suggest that TPL might be an effective therapeutic agent for treatment of T-cell lymphocytic leukemia and that its cytotoxic effects could be associated with inhibition of NF-κB and down-regulation of miR-16-1 * .

Triptolide Inhibits the Proliferation of Cells from Lymphocytic Leukemic Cell Lines in Association with Downregulation of NF-κB Activity and Mir-16-1*.

Triptolide Down-regulates Bcr-abl Expression and Induces Apoptosis in Chronic Myelogenous Leukemia Cells

Inhibition of Hsp90 by Triptolide (tpl) Augments Bortezomib-Induced U266 Cells Apoptosis

Antitumor Effect of Triptolide in T-cell Lymphoblastic Lymphoma by Inhibiting Cell Viability, Invasion, and Epithelial–mesenchymal Transition Via Regulating the PI3K/AKT/mTOR Pathway

Triptolide Inhibits Transcription Factor Nf-Kappab and Induces Apoptosis of Multiple Myeloma Cells

Triptolide Induces Apoptosis in Myelodysplastic Syndromes MUTZ-1 Cells Through Activation of Caspases and Down-Regulation of IAPs

Triptolide Enhances the Sensitivity of Multiple Myeloma Cells to Dexamethasone Via Micrornas.

Triptolide, a Chinese Herbal Extract, Enhances Drug Sensitivity of Resistant Myeloid Leukemia Cell Lines Through Downregulation of HIF-1α and Nrf2.

Triptolide Inhibits T-cell Acute Lymphoblastic Leukaemia by Affecting Aberrant Epigenetic Events in the Wnt Signalling Pathway.

Triptolide Inhibits Cell Growth and Induces G0-G1 Arrest by Regulating P21wap1/Cip1 and P27 Kip1 in Human Multiple Myeloma Rpmi-8226 Cells

The roles of TPL in hematological malignancies

Triptolide Inhibits Tumor Growth by Induction of Cellular Senescence.

Triptolide Inhibits Cyclooxygenase-2 and Inducible Nitric Oxide Synthase Expression in Human Colon Cancer and Leukemia Cells

Triptolide-induced Apoptosis by Inactivating Nuclear Factor-Kappa B Apoptotic Pathway in Multiple Myeloma in Vitro

Triptolide Enhances the Sensitivity of Pancreatic Cancer PANC-1 Cells to Gemcitabine by Inhibiting TLR4/NF-κB Signaling.

NF-κB signaling inhibition and anticancer activities of LLDT-246 on human colorectal cancer HCT-116 cells in vitro.

Triptolide Induces Apoptosis and Inhibits the Growth and Angiogenesis of Human Pancreatic Cancer Cells by Downregulating COX-2 and VEGF.

Triptolide Induces Mitochondria-Mediated Apoptosis of Burkitt's Lymphoma Cell Via Deacetylation of GSK-3β by Increased SIRT3 Expression.

Triptolide Induces S Phase Arrest Via the Inhibition of Cyclin E and CDC25A and Triggers Apoptosis Via Caspase- and Mitochondrial-Dependent Signaling Pathways in A375.S2 Human Melanoma Cells

Low-dose Triptolide in Combination with Idarubicin Induces Apoptosis in AML Leukemic Stem-Like KG1a Cell Line by Modulation of the Intrinsic and Extrinsic Factors.

Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells